Synthesis and evaluation of a series of quinolinyl trans-cyanostilbene analogs as anticancer agents
Synthesis and evaluation of a series of quinolinyl trans-cyanostilbene analogs as anticancer agents
复制标题
DOI：
10.1039/c4md00115j
复制
发表时间：
2014-01-01
期刊：
影响因子：
--
通讯作者：
Crooks, Peter A.
中科院分区：
文献类型：
--
作者：
Penthala, Narsimha Reddy;Janganati, Venumadhav;Crooks, Peter A.
A series of novel trans-2-quinolyl-, 3-quinolyl-and 4-quinolyl cyanostilbene derivatives were synthesized as analogs of combretastatin A-4 (CA-4), and evaluated for anticancer activity against a panel of 60 human cancer cell lines. The quinolin-2-yl and quinolin-3-yl analogs containing trimethoxyphenyl (10 and 16, respectively) or dimethoxyphenyl (12 and 18, respectively) moieties showed growth inhibition against all the cancer cell lines in the panel, with GI(50) values generally < 1 mu M. Quinolin-2-yl-analog 10 exhibited potent growth inhibition against MDA-MB-435 melanoma and NCI-H522 non-small cell lung cancer line with GI(50) values of 33 nM and 37 nM respectively. Quinolin-2-yl-analog 12 showed potent growth inhibition against NCI-H522 non-small cell lung cancer lines with a GI(50) value of 94 nM. Quinolin-3-yl-analog 18 exhibited potent growth inhibition against MDA-MB-435 melanoma and NCI-H522 non-small cell lung cancer lines with GI(50) values of 53 nM and 69 nM, respectively. Thus, structural modification of the CA-4 molecule has afforded compounds with potential clinical utility in the treatment a variety of different solid tumors.
